Press releases - 2019

Domain Therapeutics and Pr Michel Bouvier (IRIC Montreal) receive the RSRI award for bioSens-All™ ...

Domain Therapeutics reaches two milestones in multi-target research collaboration with Boehringer In...

Domain Therapeutics invests in Ermium Therapeutics to develop first-in-class CXCR4 candidate for aut...

Domain Therapeutics appoints Xavier Leroy as chief technology officer

Domain Therapeutics strengthens its scientific advisory board with leading GPCR and disease experts

Domain Therapeutics appoints Sylvie Ryckebusch to board of directors

European Venture Capital Firm Seventure Partners renews its support to Domain Therapeutics and inves...